The increasing interest in potent weight management has resulted in considerable exploration into groundbreaking treatments. Recently , Retatrutide, a twin-action glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor stimulator, has shown encouraging results in patient trials, sug